Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesMicroRNAs and their potential for translation in prostate cancer
Urologic Oncology: Seminars and Original Investigations, 06/30/09
deVere White RW et al. - miRNA-125b, at least in the CaP cell lines tested, is involved in the development of castrate resistance. While clearly this miRNA is only part of the answer, miRNAs may lead us in a new direction in trying to solve the central problem in CaP.
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer
Cancer Research, 11/03/09
Sexual Arousal by Higher- and Lower-Ranking Partner: Manifestation of a Mating Strategy
The Journal of Sexual Medicine, 11/03/09
Reduced Labial Temperature in Response to Sexual Films with Distractors among Women with Lower Sexual Desire
The Journal of Sexual Medicine, 11/03/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Zinc and prostatic cancer
Current Opinion in Clinical Nutrition & Metabolic Care, 10/14/09
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
Annals of Oncology, 10/16/09
Article Search
Sponsor